Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to ...

TangGene names former GSK SVP Catherine Sohn as Senior Strategic Advisor, strengthening leadership as it advances a first-in-class in-vivo CD8⁺ Treg therapy. TangGene’s in-vivo CD8⁺ Treg approach has ...

A new Science study shows that blocking an ageing-linked protein can regenerate knee cartilage and prevent arthritis in mice, ...

Parvalbumin cells play a central role in keeping brain activity in equilibrium. They control nervcell signaling, reduce ...

Tiny, sun-powered organisms found in freshwater pools could soon fuel Hawaiʻi's sustainable future. Researchers at the ...